terraxin 15 + 5 + 1 mg/ml øjen- og øredråber, suspension
nordic prime aps - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vacciner - active immunisation against h5 subtype of influenza a virus.
fusidinsyre/hydrocortisonacetat "2care4" 10+20 mg/g creme
2care4 aps - fusidinsyre, hydrocortisonacetat - creme - 10+20 mg/g
zoviduo 50 mg/g+10 mg/g creme
haleon denmark aps - aciclovir, hydrocortison - creme - 50 mg/g+10 mg/g
colifoam 100 mg/dosis rektalskum
2care4 aps - hydrocortisonacetat - rektalskum - 100 mg/dosis
solu-cortef 100 mg pulver og solvens til injektionsvæske, opløsning
orifarm a/s - hydrocortisonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 100 mg
solu-cortef 250 mg pulver og solvens til injektionsvæske, opløsning
paranova danmark a/s - hydrocortisonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 250 mg
solu-cortef 250 mg pulver og solvens til injektionsvæske, opløsning
pfizer aps - hydrocortisonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 250 mg
cortavance
virbac s.a. - hydrocortisonacceponat - corticosteroider, dermatologiske præparater - hunde - til symptomatisk behandling af inflammatoriske og pruritiske dermatoser hos hunde. for alleviation of clinical signs associated with atopic dermatitis in dogs.
protopic
leo pharma a/s - tacrolimus - dermatitis, atopisk - andre dermatologiske præparater - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. der forekommer fire eller flere gange om året), der har haft en indledende reaktion på højst seks uger behandling af to gange dagligt tacrolimus salve (læsioner ryddet, næsten ryddet eller let påvirket).